US drugmaker Pfizer Inc&nbsp;said on Tuesday (Jan 17) it will offer its full portfolio of drugs, including off-patent medicines such as chemotherapies and oral cancer treatments, on a not-for-profit basis to 45 low-income countries in the world.

In an expansion of the company's "An Accord for a Healthier World" programme, which is aimed at increasing access to innovative treatments in some of the world's poorest countries, Pfizer said it will now offer a total of 500 products.

When the drugmaker launched the programme in May 2022, it offered only its patented medicines including Covid-19 treatment Paxlovid and its big-selling breast cancer drug, Ibrance, at a not-for-profit price.

ALSO READ:&nbsp;<a href="https://www.asiaone.com/world/pfizer-ceo-rules-out-generic-covid-drug-paxlovid-china" target="_blank">Pfizer CEO rules out generic Covid drug Paxlovid for China</a>

A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken on Sept 21, 2021.

medicine

PHARMACEUTICALS

Public health and hygiene

Healthcare

poverty

Reuters

US drugmaker Pfizer Inc said on Tuesday (Jan 17) it will offer its full portfolio of drugs, including off-patent medicines such as chemotherapies and oral cancer treatments, on a not-for-profit basis to 45 low-income countries in the world. In an expansion of the company's "An Accord for a Healthier World" programme, which is aimed at increasing access to innovative treatments...

Pfizer to sell all its drugs in low-income countries at non-profit price